Jia H - Search Results

1

Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma.

Zhao T, Jia H, Cheng Q, Xiao Y, Li M, Ren W, Li C, Feng Y, Feng Z, Wang H, Zheng J. Zhao T, et al. Among authors: jia h. Oncol Rep. 2017 Jun;37(6):3405-3414. doi: 10.3892/or.2017.5629. Epub 2017 May 5. Oncol Rep. 2017. PMID: 28498414

2

Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.

Jia H, Li Y, Zhao T, Li X, Hu J, Yin D, Guo B, Kopecko DJ, Zhao X, Zhang L, Xu DQ. Jia H, et al. Cancer Immunol Immunother. 2012 Nov;61(11):1977-87. doi: 10.1007/s00262-012-1256-y. Epub 2012 Apr 18. Cancer Immunol Immunother. 2012. PMID: 22527247 Free PMC article.

3

Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.

Zhao T, Jia H, Li L, Zhang G, Zhao M, Cheng Q, Zheng J, Li D. Zhao T, et al. Among authors: jia h. Oncol Rep. 2013 Jul;30(1):377-84. doi: 10.3892/or.2013.2407. Epub 2013 Apr 18. Oncol Rep. 2013. PMID: 23595577

4

Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma.

Jia H, Zhao T, Zou D, Jia X, Gao J, Song X. Jia H, et al. Among authors: jia x. Oncol Res. 2016;23(6):321-6. doi: 10.3727/096504016X14570992647041. Oncol Res. 2016. PMID: 27131318 Free PMC article.

5

Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.

Jia H, Zhao T, Ji Y, Jia X, Ren W, Li C, Li M, Xiao Y, Wang H, Xu K. Jia H, et al. Among authors: jia x. Cell Death Dis. 2016 Dec 1;7(12):e2507. doi: 10.1038/cddis.2016.399. Cell Death Dis. 2016. PMID: 27906171 Free PMC article.

6

Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use.

Jia H, Cui J, Jia X, Zhao J, Feng Y, Zhao P, Zang D, Yu J, Zhao T, Wang H, Xu K. Jia H, et al. Among authors: jia x. Mol Med Rep. 2017 Dec;16(6):9480-9486. doi: 10.3892/mmr.2017.7825. Epub 2017 Oct 19. Mol Med Rep. 2017. PMID: 29152660 Free PMC article.

7

The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.

Jia H, Ren W, Feng Y, Wei T, Guo M, Guo J, Zhao J, Song X, Wang M, Zhao T, Wang H, Feng Z, Tian Z. Jia H, et al. Int J Oncol. 2018 Sep;53(3):949-960. doi: 10.3892/ijo.2018.4473. Epub 2018 Jul 6. Int J Oncol. 2018. PMID: 30015838 Free PMC article.

8

PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide.

Zhao T, Wei T, Guo J, Wang Y, Shi X, Guo S, Jia X, Jia H, Feng Z. Zhao T, et al. Among authors: jia x, jia h. Cell Death Dis. 2019 Feb 18;10(3):164. doi: 10.1038/s41419-019-1418-3. Cell Death Dis. 2019. PMID: 30778049 Free PMC article.

9

Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.

Zhao T, Feng Y, Guo M, Zhang C, Wu Q, Chen J, Guo S, Liu S, Zhou Q, Wang Z, Fan W, Zhang Y, Jia H, Feng Z. Zhao T, et al. Among authors: jia h. J Cell Biochem. 2020 Feb;121(2):1973-1985. doi: 10.1002/jcb.29432. Epub 2019 Nov 6. J Cell Biochem. 2020. PMID: 31692041

10

A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide.

Jia H, Guo J, Wang P, Sun K, Chen J, Ren W, Wei T, Yang Y, Li J, Liu X, Li R, Zhong J, Wang M, Tian Z, Feng Z, Zhao T. Jia H, et al. Int Immunopharmacol. 2020 Jun;83:106397. doi: 10.1016/j.intimp.2020.106397. Epub 2020 Mar 25. Int Immunopharmacol. 2020. PMID: 32220805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,527 results

Search Page

Filters